These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium. Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563 [TBL] [Abstract][Full Text] [Related]
3. K-ras mutation in focal proliferative lesions of human pancreas. Terhune PG; Phifer DM; Tosteson TD; Longnecker DS Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):515-21. PubMed ID: 9641496 [TBL] [Abstract][Full Text] [Related]
4. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983 [TBL] [Abstract][Full Text] [Related]
5. Detection of K-ras point mutation at codon 12 in pancreatic diseases: a study in a Brazilian casuistic. Kubrusly MS; Cunha JE; Bacchella T; Abdo EE; Jukemura J; Penteado S; Morioka CY; de Souza LJ; Machado MC JOP; 2002 Sep; 3(5):144-51. PubMed ID: 12221329 [TBL] [Abstract][Full Text] [Related]
6. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma. Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083 [TBL] [Abstract][Full Text] [Related]
7. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. DiGiuseppe JA; Hruban RH; Offerhaus GJ; Clement MJ; van den Berg FM; Cameron JL; van Mansfeld AD Am J Pathol; 1994 May; 144(5):889-95. PubMed ID: 8178941 [TBL] [Abstract][Full Text] [Related]
8. Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation. Arvanitakis M; Van Laethem JL; Parma J; De Maertelaer V; Delhaye M; Devière J Endoscopy; 2004 Jun; 36(6):535-42. PubMed ID: 15202051 [TBL] [Abstract][Full Text] [Related]
9. Oncogenic K-ras drives cell cycle progression and phenotypic conversion of primary pancreatic duct epithelial cells. Agbunag C; Bar-Sagi D Cancer Res; 2004 Aug; 64(16):5659-63. PubMed ID: 15313904 [TBL] [Abstract][Full Text] [Related]
10. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Moskaluk CA; Hruban RH; Kern SE Cancer Res; 1997 Jun; 57(11):2140-3. PubMed ID: 9187111 [TBL] [Abstract][Full Text] [Related]
11. Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union. Tanno S; Obara T; Fujii T; Mizukami Y; Shudo R; Nishino N; Ura H; Klein-Szanto AJ; Kohgo Y Cancer; 1998 Jul; 83(2):267-75. PubMed ID: 9669809 [TBL] [Abstract][Full Text] [Related]
12. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis. Qian J; Niu J; Li M; Chiao PJ; Tsao MS Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547 [TBL] [Abstract][Full Text] [Related]
13. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Pellegata NS; Sessa F; Renault B; Bonato M; Leone BE; Solcia E; Ranzani GN Cancer Res; 1994 Mar; 54(6):1556-60. PubMed ID: 8137263 [TBL] [Abstract][Full Text] [Related]
14. Significance of K-ras codon 12 point mutation in pancreatic juice in the diagnosis of carcinoma of the pancreas. Kimura W; Zhao B; Futakawa N; Muto T; Makuuchi M Hepatogastroenterology; 1999; 46(25):532-9. PubMed ID: 10228857 [TBL] [Abstract][Full Text] [Related]
15. Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas. Ueda S; Fukamachi K; Matsuoka Y; Takasuka N; Takeshita F; Naito A; Iigo M; Alexander DB; Moore MA; Saito I; Ochiya T; Tsuda H Carcinogenesis; 2006 Dec; 27(12):2497-510. PubMed ID: 16774944 [TBL] [Abstract][Full Text] [Related]
16. K-ras and p53 mutations in hamster pancreatic ductal adenocarcinomas and cell lines. Erill N; Cuatrecasas M; Sancho FJ; Farré A; Pour PM; Lluís F; Capellá G Am J Pathol; 1996 Oct; 149(4):1333-9. PubMed ID: 8863680 [TBL] [Abstract][Full Text] [Related]
17. The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice. Brembeck FH; Schreiber FS; Deramaudt TB; Craig L; Rhoades B; Swain G; Grippo P; Stoffers DA; Silberg DG; Rustgi AK Cancer Res; 2003 May; 63(9):2005-9. PubMed ID: 12727809 [TBL] [Abstract][Full Text] [Related]
18. High frequency of K-ras mutations in biliary duct carcinomas of cases with a long common channel in the papilla of Vater. Hidaka E; Yanagisawa A; Seki M; Takano K; Setoguchi T; Kato Y Cancer Res; 2000 Feb; 60(3):522-4. PubMed ID: 10676628 [TBL] [Abstract][Full Text] [Related]
20. Clinical and genetic analysis of noncancerous and cancerous biliary epithelium in patients with pancreaticobiliary maljunction. Nagai M; Watanabe M; Iwase T; Yamao K; Isaji S World J Surg; 2002 Jan; 26(1):91-8. PubMed ID: 11898040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]